migraines Flashcards
migraine
very common
episodic neurologic disorder
HA lasting 4- 72hr
dx
need 2 of following: unilateral head pain, throbbing pain, worse with activity, mod/severe pain
+1 of the following: n/v, photophobia, phonophobia (sound)
classification
aura present: visual, sensory, motor
aura not present: most common
chronic: usually episodic and increase in freq over time, 15 days/mo for 3 mo
rf
fam hx
estrogen and progesterone: F!, more freq before/during menstruation, decrease in preg and menopause therefore cyclic withdrawal may be trigger
genetic and env factors
triggers
fatigue, sleep disturbance (too much/little), missed meals, overexertion, weather change, stress, hormonal change, OH (red wine), bright lights, strong smells
patho
not really identifiable, complex
change in excitatory NT levels in CNS: increase neuronal depol -> hyperactivity -> vasodilate
change in brain met and BF
clinical phases: premonitory
hrs - days before onset
1/3 have fatigue, irritability, decreased [], stiff neck, food cravings
clinical phases: migraine aura
1/3 have aura S lasting up to 1 hr
clinical phases: HA
throbbing (1 sides and spread to both)
fatigue
n/v
dizzy
hypersensitivity to head touch
4-72hr
clinical phases: recovery
can linger hrs - days
irritable, fatigue, depression
pharm: abortive
more effective early
aspirin like: asa, acetaminophen, NSAID
serotonin receptor agonist (triptans): sumatriptan - usually in addition to aspirin like, combo more effective than either alone
calcitonin gene related peptide (CGRP) antagonist (if cant tolerate triptans)
antiemetics if severe n/v
pharm: preventative
> 4 migraines/mo, or >12hr, or chronic
BB: propanolol
tricyclic antidep: divalproex, topiramate
estrogens: menstrual migraine
pharm: preventative - goals
decrease attack freq, severity, duration
improve responsiveness to tm of acute attack
improve function and decrease disability, prevent progression or transformation of episodic migraine to chronic migraine
Sumatriptan
Serotonin receptor agonists
Constrict intracranial blood vessels
Suppress release of inflammatory neuropeptides
Block brain pathways for pain migraine
Injection site rxn (SQ), chest pressure, flushing, weakness, HA, bad taste (nasal)
SQ, PO, intranasal
Avoid with ischemic stroke or HD and angina
Rimegepant
CGRP antagonists
Mediate pain transmission
Migraine
GI upset PO
CYP substrate – watch for interactions, get good med hx
Used to treat acute migraine where triptans aren’t effective or CI